KLK15 Antibody (Center V146) Blocking Peptide
€363.00
In stock
SKU
AC-BP6334b
Background:
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. In prostate cancer, KLK15 has increased expression, which indicates its possible use as a diagnostic or prognostic marker for prostate cancer.
Other Names:
Kallikrein-15, 3421-, ACO protease, KLK15
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6334b was selected from the Center region of human KLK15. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: KLK15
Gene ID: 55554
Primary Accession: Q9H2R5
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. In prostate cancer, KLK15 has increased expression, which indicates its possible use as a diagnostic or prognostic marker for prostate cancer.
Other Names:
Kallikrein-15, 3421-, ACO protease, KLK15
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6334b was selected from the Center region of human KLK15. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: KLK15
Gene ID: 55554
Primary Accession: Q9H2R5
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review